Articles in Trade Journals
While Harvard Business Review is probably the preeminent management journal, there are several others that command respect and have a substantial audience of senior business people. We have helped clients place articles in many of them. Here is a selection.
Keys to Mitigating Risk in Adaptive Trials
Phase III trials are the big, expensive ones that come right before a drug is submitted to a regulatory agency for approval. Phase III trials cost about $20 million, so you can see why the fact that about 50% of them fail is a big problem. Sy Pretorius, Chief Scientific Officer of PAREXEL, a leading international pharmaceutical consulting firm, believes that high rate of failure is due to traditional rigid trial designs. He argues that adaptive designs that enable trials to change as new data is collected can reduce failures (or lead to faster trial terminations), thereby saving companies a whole lot of time and money. We helped Pretorius publish his article about how to run adaptive trials (which are more complex than traditional ones) safely and effectively in Life Science Leader, here.
Waste-Not Want-Not Formulation and Process Design
Developers must make important decisions about product formulation and process design to move a drug from preclinical through Phase II trials as quickly as possible. Over-engineering a Phase I or Phase II drug that ultimately fails in the clinic wastes resources. But neglecting sound science during early stages can result in a promising product that may not have a scalable or commercially manufacturing process.
Fighting Pharma Demand Forecast Fails
Given the long road drugs must travel to get to market, developers have to predict demand, and line up production capacity, years before a new product launches. If they guess too low, they won’t have enough to meet demand (causing reputational damage and the loss of potential revenue). If they guess too high, they’re stuck with product they can’t sell. And because forecasts are always off, James Mullen, CEO of Patheon, a global contract manufacturing firm, has a solution: flexible and scalable manufacturing capabilities.
Fighting Bribery and Fraud in Emerging Markets
Matías Mora Simoes is a Senior Managing Director in the FTI Consulting Forensic and Litigation Consulting practice and is the head of the FTI Consulting Panama and FTI Consulting Mexico offices. We helped him place his article, “What Companies Do Right (and Wrong) Fighting Bribery and Fraud in Emerging Markets,” based on FTI Consulting research, in Corporate Compliance Insights. You can read the article, here.
Converging Risks in Emerging Markets
Eighty-three percent of 150 respondents to an FTI Consulting survey reported suffering significant losses in emerging markets. Based on this research, Arun Shukla, Senior Managing Director in the Corporate Finance practice of FTI Consulting, and Andrew Klemm, a senior consultant in the same practice, wrote “Risks Converge in Emerging Markets,” which we helped them place on CFO.com. You can read the article, here.
Oil and Gas Industry Gets Social Media Wrong
Steve Everley is a Senior Director at FTI Consulting, advising clients in a broad range of industries, including coal, refining and LNG exports. Everley published an article in FTI Journal, “Drilling for a Social Media Strategy,” here, about how social media, which can target small groups and communicate with them in an intimate manner, is a better communication channel for the oil and gas industry than the national marketing efforts it has heretofore focused upon. The industry has left social media to its activist opponents. It can do so no longer.
In December, we helped Everley publish a version of his FTI Journal article in industry publication OGI, here.
Hard and Necessary: End-of-Life Discussions
Studies have shown that people who have advance end-of-life planning discussions with their physicians spend less time receiving painful, unwanted, expensive, and ultimately futile treatments under the cold, blinking lights of Intensive Care Units. Instead, they get to spend that time with their loved ones. Unfortunately, these discussions happen all too infrequently as physicians are not trained to conduct them and families are often unfamiliar with the process. In this article that the Bloom Group helped FTI Consulting Senior Managing Director/Health Solutions Kerry Shannon place in McKnight's Long Term Care News, Shannon argues that long-term care facilities need to make sure these conversations take place, and she explains how. You can read the article here.
Banks Vs. the Bad Guys: CFO.com
Governments increasingly are casting banks in the role of the global economy's first line of defense against money laundering and other financial activities that support criminals, terorrists and rogue nations. And regulators are enforcing that view by levying increasingly high fines against banks that have been used by criminals and terrorists (or the nations that support them). Financial institutions have no choice but to comply, and so they need to build functions and risk-based processes that will reduce their risk of being used by the bad guys.
Peter Brooke and Christine Moran, managing directors in the governance, risk and regulation team at FTI Consulting, have proposed several ways that financial institutions can do well by doing good: implementing policies that will reduce their risk of running afoul of the regulators and help de-fund criminals and terrorists. We worked with them to help publish this article on CFO.com.
Big Data: InfoWeek
CapTech consultants Todd Homa and Harlan Bennett help clients design and implement Big Data solutions. From their client work they have developed approaches and a point of view about how clients can quickly and effectively get value from Big Data, without necessarily spending huge amounts on technology -- often, in fact, using largely the technology they already have. We helped them capture that expertise in a whitepaper, and then derived an article for InformationWeek, which you can read here.